Early screening, standardized diagnosis and treatment as well as effective management are keys to improve the control level and quality of life in patients with bronchial asthma (BA) , a common chronic airway disease. Frequent acute attacks of BA are associated with decreased quality of life, increased medical costs, and increased economic burden of patients. The management level of BA has increased in urban areas, but is still low in rural areas in China. To improve the level of early screening and diagnosing BA in community healthcare settings, and to enhance primary physicians' capability of standardized diagnosis and management of BA, Shenzhen Group of Integrated Medical and Preventive Medicine Program for Respiratory Diseases developed an early screening program and an standardized management pathway for BA after a group discussion based on relevant BA guidelines and consensuses that are applicable to Shenzhen community healthcare settings.
